In September 2024, pharmaceutical manufacturer Pfizer issued a global recall of Oxbryta, a medication that provided critical treatment to patients with sickle cell disease. Millions of people around the world struggle with this condition, and Oxbryta has served as a …
Every year, dangerous prescription medications harm Americans through severe side effects, complications, and interactions that pharmaceutical companies fail to disclose. When the U.S. Food and Drug Administration (FDA) identifies potential safety concerns with an approved drug, their actions can mean …
Sickle cell disease causes red blood cells to become misshapen, causing millions of people to suffer from complications like severe pain, organ damage, and life-threatening infections. Oxbryta was a prescription medication that helped prevent red blood cells from becoming sickle-shaped, …
All fields required *
